HROW:NASDAQ
Harrow Inc
$ 28.38
arrow_upward
+1.12%(+0.32) 1D
10-р сарын 21, 13:07:35 (GMT-4) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HROW...
Open
$ 28.26
High
$ 28.66
Low
$ 27.98
Mkt. cap
1.06 тэрбум
Avg. vol.
628.92 мян
Volume
195.40 мян
52-wk high
$ 54.85
52-wk low
$ 26.96
EPS
-$ 1.00
Beta
0.19
Shares outstanding
37.49 сая
No. of employees
373
Open
$ 28.26
High
$ 28.66
Low
$ 27.98
Mkt. cap
1.06 тэрбум
Avg. vol.
628.92 мян
Volume
195.40 мян
52-wk high
$ 54.85
52-wk low
$ 26.96
EPS
-$ 1.00
Beta
0.19
Shares outstanding
37.49 сая
No. of employees
373
News stories
From web sources and news partners
TradingView
·
1 цагийн өмнө
TruGolf Holdings (NASDAQ: TRUG) Completes Polymath Acquisition, Offering Expansion into Institutional Tokenization
Finimize
·
6 минутын өмнө
SpaceX And Super Micro Lead A Tech-Led Stock Bounce
Yahoo Finance UK
·
57 минутын өмнө
Quik! CEO Rich Walker to Deliver Keynote Presentation at The Wealth Mosaic Live 2026: US Event at Nasdaq MarketSite
Investor's Business Daily
·
2 цагийн өмнө
These Stocks Get Biggest Estimate Increases Ahead Of Earnings
Profile
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
Since 2014, Harrow has started six healthcare businesses, including ImprimisRx, an ophthalmic-focused pharmaceutical company. In 2017, Harrow started and funded Eton Pharmaceuticals with a $20 million Series A financing, and Eton is now a publicly traded company. In 2017, Harrow started Surface Pharmaceuticals, hiring Dr. Kamran Hosseini to be its chief executive officer. Surface was funded with a $20 million Series A financing with Flying L Partners leading the round. In 2018, Harrow started Melt Pharmaceuticals and announced an $11 million Series A financing.
In 2019, Harrow hired founder and former CEO of Doxy.me, Drew Livingston, as its chief innovation officer. Livingston is the senior executive of Harrow's Visionology.com telemedicine subsidiary. Wikipedia
About Harrow Inc
CEOMark L. Baum Esq.
Employees373
Founded2012
HeadquartersНэшвиль, Теннесси, Америкийн Нэгдсэн Улс
SectorPharmaceutical industry
Websiteharrow.com